Form 8-K - Current report:
SEC Accession No. 0001479681-24-000016
Filing Date
2024-11-07
Accepted
2024-11-07 16:07:53
Documents
17
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nutx-20241107x8k.htm   iXBRL 8-K 29692
2 EX-99.1 nutx-20241107xex99d1.htm EX-99.1 435033
3 GRAPHIC nutx-20241107xex99d1001.jpg GRAPHIC 4252
  Complete submission text file 0001479681-24-000016.txt   650914

Data Files

Seq Description Document Type Size
4 EX-101.SCH nutx-20241107.xsd EX-101.SCH 4391
5 EX-101.DEF nutx-20241107_def.xml EX-101.DEF 2857
6 EX-101.LAB nutx-20241107_lab.xml EX-101.LAB 12255
7 EX-101.PRE nutx-20241107_pre.xml EX-101.PRE 11787
19 EXTRACTED XBRL INSTANCE DOCUMENT nutx-20241107x8k_htm.xml XML 4833
Mailing Address 6030 S. RICE AVE. SUITE C HOUSTON TX 77081
Business Address 6030 S. RICE AVE. SUITE C HOUSTON TX 77081 (713) 660-0557
Nutex Health, Inc. (Filer) CIK: 0001479681 (see all company filings)

EIN.: 113363609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41346 | Film No.: 241435624
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)